Loading provider…
Loading provider…
Pulmonary Disease Physician in Portland, ME
NPI: 1043313356Primary Practice Location
MAINEHEALTH MAINE MEDICAL CENTER
22 Bramhall St, Portland, ME
Primary Employer
Chest Medicine Associates, PA
cmamaine.com
HQ Phone
Get MD Jonathan's Phone Numberphone_androidMobile
Get MD Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardME State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 27 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 11 | 11 |
| 3 | 94729Measurement of lung diffusing capacity | 11 | 11 |
| 4 | 94375Test to measure rate of airflow | 11 | 11 |
Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis.
Authors: Moira Aitken, David Geller, Patrick Flume, Allen Lapey
Journal: J Cyst Fibros
Publication Date: 2012-12-09
Urinary stone disease prevalence and associations in cystic fibrosis.
Complications of long and intermediate term venous catheters in cystic fibrosis patients: A multicenter study.
Authors: Teresa May, Alexandra Cornell
Publication Date: 2017-03-07
Lead Sponsor: Laurent Pharmaceuticals Inc.
Collaborators: Cystic Fibrosis Foundation
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: LAU-7b
Lead Sponsor: Dartmouth-Hitchcock Medical Center
Collaborators: MaineHealth
Intervention / Treatment: OTHER: Adults - CFPE Treatment
Lead Sponsor: Celtaxsys, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: CTX-4430